Illinois General Assembly - Bill Status for SB1553

Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.

Actions

Date	Chamber	Action
2/4/2025	Senate	Filed with Secretary by Sen. Patrick J. Joyce
2/4/2025	Senate	First Reading
2/4/2025	Senate	Referred to Assignments
2/11/2025	Senate	Assigned to Criminal Law
2/19/2025	Senate	To Criminal Law Clear Compliance
3/21/2025	Senate	Rule 2-10 Committee Deadline Established As April 4, 2025

×